[Focus on Acinetobacter baumannii].
Acinetobacter baumannii carbapeneme-resistance is a serious problem due to the difficulty encountered in treating patients infected with this type of multiresistant bacteria. Several teams have detailed the resistance mechanisms and the way this type of strain spreads around the world. Different factors (plasmid transmission, strain variability) suggest that this type of resistance can diffuse and tends to increase with time. A NEW STRAIN: An outbreak of 15 colonizations with Acinetobacter baumannii, a BLSE producing a type PER-1 enzyme, was described in a neurosurgery intensive care unit in Great Britain. This type of strain has been exception to data and this outbreak emphasizes the problems encountered in controlling the epidemic.
Joly-Guillou
M L
ML
Service de Microbiologie, Hôpital Louis Mourier, Colombes.
D000150:Acinetobacter / Q000187:drug effects*; D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000635:transmission; D015780:Carbapenems / Q000009:adverse effects / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000635:transmission; D004196:Disease Outbreaks; D018432:Drug Resistance, Multiple; D006801:Humans; D007362:Intensive Care Units
D015780:Carbapenems